Plain-English translation of NCT06069973 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing whether special blood tests and non-invasive monitoring devices can detect early warning signs of a serious brain complication that sometimes develops after certain types of brain bleeding. The study will collect blood samples and monitor heart rate, brain oxygen levels, and brain wave activity in patients who have had this type of brain hemorrhage. By using artificial intelligence to find patterns in this data, doctors hope to catch complications early and act quickly to prevent permanent damage.
After a specific type of brain bleed, some patients develop reduced blood flow to the brain days later, which can cause lasting harm or death. Currently, doctors don't have a reliable, quick way to detect when this is about to happen. This trial aims to develop an early warning system so doctors can intervene before damage occurs.
You likely qualify if…
You likely don't qualify if…
You will have blood samples drawn at regular intervals while you are in the intensive care unit. You will also wear non-invasive monitoring equipment that tracks your heart rate, brain oxygen levels, and brain wave activity — similar to equipment commonly used in hospitals. Researchers will follow your health outcomes at 1 year, 3 years, and 5 years after your hospital admission to see how the blood markers and monitoring data relate to your recovery.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
Sweden
Sponsor
Sahlgrenska University Hospital
Enrollment target
~1,500 participants
Started
January 2024
Primary completion
December 2033
Age range
18 Years – 110 Years
Last updated on clinicaltrials.gov in January 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.